161 related articles for article (PubMed ID: 6239013)
1. Abnormal indomethacin-sensitive suppression in peripheral blood mononuclear cells of cancer patients restricts augmentation by interleukin-2.
Braun DP; Harris JE
J Biol Response Mod; 1984 Oct; 3(5):533-40. PubMed ID: 6239013
[TBL] [Abstract][Full Text] [Related]
2. In vitro inhibition of interleukin-2 production by peripheral blood lymphocytes from stage III melanoma patients by prostaglandin E2: enhancement of lymphocyte proliferation by exogenous interleukin-2 plus indomethacin.
Murray JL; Dowd J; Hersh EM
J Biol Response Mod; 1986 Feb; 5(1):12-9. PubMed ID: 3485703
[TBL] [Abstract][Full Text] [Related]
3. Relationship of leukocyte numbers, immunoregulatory cell function, and phytohemagglutinin responsiveness in cancer patients.
Braun DP; Harris JE
J Natl Cancer Inst; 1981 Oct; 67(4):809-14. PubMed ID: 6974273
[TBL] [Abstract][Full Text] [Related]
4. Effect of combination chemotherapy on PGE-mediated immunoregulation in the peripheral blood mononuclear cells of solid tumor cancer patients.
Braun DP; Harris JE
J Biol Response Mod; 1984 Aug; 3(4):391-6. PubMed ID: 6434702
[TBL] [Abstract][Full Text] [Related]
5. The effects of indomethacin and interleukin-2 on the proliferation of lymphocytes from patients with lung cancer.
Maca RD; Burford JG; Taylor RT
J Clin Immunol; 1985 May; 5(3):158-65. PubMed ID: 3874210
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 2 (IL 2) relationships with the cancer-related immunodeficiency: in vitro response to exogenous IL 2 by PHA-activated and non PHA-activated peripheral blood mononuclear cells from cancer patients.
Mantovani G; Coiana A; Massidda A; Proto E; Floris C; Macciò A; Pusceddu G; Del Giacco GS
Diagn Clin Immunol; 1987; 5(2):104-11. PubMed ID: 3497733
[TBL] [Abstract][Full Text] [Related]
7. Effect of interferon therapy on indomethacin-sensitive immunoregulation in the peripheral blood mononuclear cells of renal cell carcinoma patients.
Braun DP; Harris ZL; Harris JE; Sandler S; Khandekar J; Locker G; Haid M; Gordon L; Shaw J; Cobleigh M
J Biol Response Mod; 1983; 2(3):251-62. PubMed ID: 6196453
[TBL] [Abstract][Full Text] [Related]
8. Immune dysfunction in primary biliary cirrhosis (PBC): I. Increased sensitivity of PHA stimulated lymphocyte cultures to indomethacin.
Licastro F; Lenzi M; Chiricolo M; Davis LJ; Cassani F; Bianchi F; Franceschi C
J Clin Lab Immunol; 1987 May; 23(1):19-23. PubMed ID: 3612758
[TBL] [Abstract][Full Text] [Related]
9. Role of interleukin-2 (IL-2) in cancer-related immune deficiency: in vitro response to IL-2, production of IL-2, and IL-2 receptor expression in patients with advanced cancer.
Mantovani G; Coiana A; Massidda A; Proto E; Floris C; Macciò A; Pusceddu G; Del Giacco GS
Cancer Detect Prev; 1988; 12(1-6):149-59. PubMed ID: 3263194
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 2 defect in the peripheral blood and the lung in patients with Sjögren's syndrome.
Miyasaka N; Murota N; Yamaoka K; Sato K; Yamada T; Nishido T; Okuda M
Clin Exp Immunol; 1986 Sep; 65(3):497-505. PubMed ID: 3490935
[TBL] [Abstract][Full Text] [Related]
11. Suppressor cells in melanoma and lung cancer: correlation with the clinical stage.
Minassian AA; Kadagidze ZG
Neoplasma; 1983; 30(2):153-8. PubMed ID: 6221196
[TBL] [Abstract][Full Text] [Related]
12. Indomethacin sensitive suppressor cells in Crohn's disease: a possible role in decreased lymphocyte responsiveness.
Victorino RM
J Clin Lab Immunol; 1983 Aug; 11(4):197-201. PubMed ID: 6230454
[TBL] [Abstract][Full Text] [Related]
13. In vitro effect of indomethacin on mitogen-induced lymphoproliferative response in lung cancer patients.
Stanojević-Bakić N; Vucković-Dekić L; Susnjar S; Spuzić I
Neoplasma; 1992; 39(2):129-32. PubMed ID: 1326720
[TBL] [Abstract][Full Text] [Related]
14. Immunoregulatory cell function in peripheral blood leukocytes of patients with intracranial gliomas.
Braun DP; Penn RD; Flannery AM; Harris JE
Neurosurgery; 1982 Feb; 10(2):203-9. PubMed ID: 6280097
[TBL] [Abstract][Full Text] [Related]
15. [p55 and p75 subunits of the IL 2 receptor, membrane bound and soluble, in peripheral lymphocytes in patients with solid tumors].
Mantovani G; Macciò A; Contini L; Esu S; Littera S; Lai P; Proto E; Balestrieri A; Del Giacco GS
Recenti Prog Med; 1993 Jun; 84(6):415-22. PubMed ID: 8516548
[TBL] [Abstract][Full Text] [Related]
16. Mitogenic response and interleukin 2 production in Crohn's disease.
Miura M; Hiwatashi N
J Clin Lab Immunol; 1987 Nov; 24(3):113-6. PubMed ID: 3501474
[TBL] [Abstract][Full Text] [Related]
17. Strong prostaglandin associated suppression of the proliferation of human maternal lymphocytes by neonatal lymphocytes linked to T versus T cell interactions and differential PGE2 sensitivity.
Papadogiannakis N; Johnsen SA; Olding LB
Clin Exp Immunol; 1985 Jul; 61(1):125-34. PubMed ID: 2931220
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients.
Balch CM; Dougherty PA; Cloud GA; Tilden AB
Surgery; 1984 Jan; 95(1):71-7. PubMed ID: 6229053
[TBL] [Abstract][Full Text] [Related]
19. Human bone marrow allograft recipients: production of, and responsiveness to, interleukin 2.
Warren HS; Atkinson K; Pembrey RG; Biggs JC
J Immunol; 1983 Oct; 131(4):1771-5. PubMed ID: 6352802
[TBL] [Abstract][Full Text] [Related]
20. Studies on lymphocyte hyporesponsiveness in cirrhosis: the role of increased monocyte suppressor cell activity.
Holdstock G; Chastenay BF; Krawitt EL
Gastroenterology; 1982 Feb; 82(2):206-12. PubMed ID: 6459260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
